Comment on: Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational study
J Antimicrob Chemother
.
2023 Dec 1;78(12):3009-3010.
doi: 10.1093/jac/dkad318.
Authors
Andrea Giacomelli
1
,
Maria Vittoria Cossu
2
,
Davide Moschese
2
,
Cristina Gervasoni
1
3
Affiliations
1
III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Via G.B. Grassi 74, 20157 Milan, Italy.
2
I Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy.
3
Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli-Sacco University Hospital, Milan, Italy.
PMID:
37823428
DOI:
10.1093/jac/dkad318
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anti-Retroviral Agents / therapeutic use
HIV Infections* / drug therapy
Humans
Lamivudine* / therapeutic use
Pyridones / therapeutic use
Substances
Lamivudine
doravirine
Anti-Retroviral Agents
Pyridones